The VCCC Alliance is a powerful partnership between 10 leading research, academic and clinical institutions working together to expedite and amplify leading-edge cancer research, knowledge and expertise to improve outcomes for people affected by cancer.
Through innovation and collaboration, our alliance is leading integrated, research-driven, consumer-informed cancer research, education and patient care. By capitalising on our collective strengths, we are fundamentally changing the way we tackle cancer and accelerating the translation of scientific evidence into patient benefit.
The new VCCC Alliance Strategic Program Plan 2021-24 is a roadmap of integrated, innovative and ambitious programs designed to tackle the complexities and inequities of cancer outcomes in Victoria. Read more and discover the 10 programs that aim to shift the dial in key areas of need and opportunity over the next three years.
As we approach the end of 2021 there is much to reflect upon. The Danish philosopher Soren Kierkegaard said we can only understand our life by looking backwards, but we must live it looking forwards.
In some ways, the monumental loss of normalcy encountered this year gave those of us working in health and medical research even greater insight into the effects of the stress and strong emotions that are commonly felt by those who experience a cancer diagnosis.
First allied health cancer clinical trials unit to be based in regional Victoria
A new allied health cancer clinical trials unit specialising in cancer supportive care and survivorship is to be established, thanks to a recent grant co-funded by Cancer Council Victoria and the Victorian Government through the Victorian Cancer Agency.
The three-year project will bring together consumers and leaders from Barwon Health’s Allied Health, Cancer Services and Clinical Trials teams to design and develop a unique Allied Health Clinical Trials Unit based at the Adrian Costa Clinical Trials Centre.
Easing access for patients undergoing CAR T-cell therapy
A new initiative from the VCCC Alliance Research and Education Lead (R&E Lead) Haematology program, led by Professor Con Tam is seeking to improve access to CAR T-cell therapy for patients undergoing treatment for blood cancer.
The relatively new therapy is an exciting prospect for clinicians and patients thanks to advances in genomic medicine, however it is a long and uncertain process, and not every patient will elect to pursue it. For this reason, the VCCC Alliance R&E Lead program has been liaising with haematologists across the state to explore practical ways of removing some of the barriers to treatment.
The third annual consumer engagement forum on Friday 3 December, hosted by the VCCC Alliance Cancer Consumer Advisory Committee (CCAC) brought consumers and researchers together to learn about the potential for consumer advocacy, hear how consumers are having a greater say in research funding and how effective partnerships can shift the paradigm in both cancer research and education.
It was a major step forward in consumer-led initiatives, initiating a proactive discussion with funding agencies about involvement with grant applications.
The Australian Brain Cancer Research Alliance (ABCARA) is a new alliance of brain cancer focused researchers and clinician scientists with an interest in adult brain cancer research.
The alliance is seeking to develop a national research collaboration to accelerate developments in brain cancer research and patient outcomes. A first step is to understand the scope of research and use of technology among peers nationwide. A full day symposium will precede the COGNO Annual Scientific Meeting later this month to discuss challenges and opportunities for building a collaborative adult brain cancer network.
Collaborative trial investigates potential for the management of patients with non-small cell lung cancer
An NHMRC-funded investigator-initiated trial has commenced in Victoria with around 100 patients recruited from across VCCC Alliance hospitals. The study is evaluating novel assays to detect circulating tumour DNA (ctDNA) before and after lung cancer surgery.
There are currently no sensitive or specific blood-based biomarkers in clinical use for lung cancer, so the study aims to develop and validate molecular predictive and prognostic markers to improve outcomes for patients with the disease.
The theme for the 2020-21 Annual Report is The Great Reset, reflecting the progression from our Strategic Research Plan 2017-20 to our new Strategic Program Plan, overlaid by our experiences and lessons as research, health and academic institutions during a pandemic.
In FY 20/21, the remaining objectives for the Strategic Research Plan 2017-20 were realised and the final evaluation was submitted to the Victorian Department of Health in October 2020.
If Not Me, Who? If Not Now, When? Close the Care Gap
In 2022, the Union for International Cancer Control will begin a new three-year 'Close the Care Gap' campaign designed to raise awareness about the numerous barriers that exist for people around the world in accessing the cancer care they need. Prof Sanchia Aranda, past president of the UICC and Deputy Chair VCCC Alliance and Dr Kalinda Griffiths, new VCCC Alliance Research and Education Lead for Aboriginal and Torres Strait Islander Health will lead an important discussion.
SunWatch: wearable photodetector for real time UV monitoring
Join Head of the NanoTech Laboratory at Macquarie University, for an informative look at SunWatch, a personalised technology platform to measure sun exposure. This innovation has the potential to save lives and dramatically reduce treatment costs for melanoma and other skin cancers.
Monday Lunch Livestream: NanoMslide - new slide technology for early-stage cancer diagnosis
Join a collaborative team of researchers led by Professor Brian Abbey (La Trobe Institute for Molecular Sciences) and Associate Professor Belinda Parker (Peter MacCallum Cancer Centre), who have been trialling a new alternative technology for cancer detection. NanoMslide: a cutting-edge nanotechnology to transform the humble microscope slide into a potential new tool for cancer diagnosis.
Deputy Chair - Cancer Consumer Advisory Committee - Regional member sought
We are seeking a highly motivated cancer consumer from regional Victoria with experience in contributing to the setting of strategic direction, collaborating with multidisciplinary stakeholders and capacity to be part of a dynamic committee.
Deputy Chair - Cancer Education and Training Advisory Committee
We are seeking expressions of interest for the new position of Deputy Chair, VCCC Alliance Cancer Education and Training Advisory Committee. You will join a community of like-minded professionals striving to foster an outstanding cancer workforce to help maintain and enhance world-leading cancer outcomes.
Peter Mac is Australia’s only integrated cancer research, treatment and education centre, with multidisciplinary teams that provide care informed by precision in fundamental, translational and clinical research.
The Royal Melbourne Hospital
The Royal Melbourne Hospital (Melbourne Health) provides high-quality cancer treatment programs, translational research, and surgical and medical expertise, as well as other key support services such as clinical care and emergency medicine.
University of Melbourne
Australia’s first ranked research university and medical school, the university provides academic and research expertise to the alliance.
The Royal Women's Hospital
The Women’s provides specialist cancer services for women with breast and gynecological cancer and conducts research into the treatment and care of women with cancer, as well as the specific impacts of gender on cancer.
WEHI is one of Australia’s leading biomedical research organisations, with a strong national and international reputation for performing highly influential basic and translational research.
The Royal Children's Hospital
The Children’s Cancer Centre is the only provider of complex children’s cancer care and stem cell transplantation in Victoria and is a leader in the research and treatment of childhood cancer.
Western Health is the largest provider of treatment for colorectal cancer and a leader in the treatment of upper gastro-intestinal cancers with programs in breast, lung, genitourinary, gynaecology and haematological cancer.
Western Health has on-site radiation therapy and chemotherapy facilities and has a strong palliative care service.
St Vincent's Hospital Melbourne | St Vincent's Institute
A leader in palliative care practice and complex cancer surgery, St Vincent’s Hospital Melbourne also provides oncology and haematology services, on-site radiation therapy and chemotherapy facilities, in addition the hospital houses the Victorian-wide psycho-oncology service.
The hospital shares its campus with St Vincent's Institute, which has fundamental and clinical researchers working on mechanisms of cancer and diseases of cancer survivorship.
Austin Health | Olivia Newton-John Cancer Research Institute
The Olivia Newton-John Cancer Wellness & Research Centre at Austin Health provides world-leading specialist treatment and holistic care including clinical trials both independently and in partnership with the Olivia Newton-John Cancer Research Institute (ONJCRI) – a leader in the development of experimental and breakthrough cancer treatments only metres from where patients are cared for.
Murdoch Children's Research Institute
The MCRI is a leader in understanding the underlying mechanisms and treatment of paediatric cancer and is home to the Children’s Cancer Tissue bank; a world class resource for researchers studying rare solid tumours and leukemia.